Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Biotech/Pharma - Alliances
Kyocera Corporation (KYO) Joins Imec's Industrial Affiliation Program On Advanced Silicon Solar Cell Technology 9/23/2014 11:39:23 AM
FORMA Therapeutics, Inc. And H. Lee Moffitt Cancer Center & Research Institute Establish Multiyear Epigenetics Alliance 9/23/2014 10:52:37 AM
Calixar And Virpath Develop An Innovative Manufacturing Process For High Performance Influenza Vaccines 9/23/2014 10:38:44 AM
Mabion Signed An Agreement For The Realization Of A Clinical Trial Of The Drug MabionHER2 9/23/2014 10:34:13 AM
Renewal Of The Sanofi-GENFIT Corp. (ALGFT) Agreement 9/23/2014 10:02:14 AM
Tekmira Pharmaceuticals Corporation (TKMR) Joins International Consortium To Conduct Clinical Trials Of Ebola Virus Therapeutics In West Africa 9/23/2014 8:12:26 AM
Rhizen Pharmaceuticals S.A. Announces Out-Licensing Agreement For TGR-1202, A Novel Next Generation PI3K-Delta Inhibitor 9/23/2014 9:10:10 AM
Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan-Kettering Cancer Center 9/23/2014 9:08:10 AM
Novavax, Inc. (NVAX) Announces Biomedical Advanced Research and Development Authority (BARDA) Exercise Of Contract Option 9/23/2014 8:25:00 AM
Cancer Genetics, Inc. (CGIX) And Beth Israel Deaconess Medical Center Enter Into Collaboration To Correlate Genomic Profiles To Patient Outcome In Diffuse Large B-Cell Lymphoma 9/23/2014 8:16:10 AM
TG Therapeutics, Inc. (MHA) Announces Exercise Of License Option For Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202 9/23/2014 8:14:36 AM
Innovus Pharma, Orimed Pharma Ink $94.5 Million+ Zestra® Pact 9/22/2014 7:35:35 AM
University of California, San Francisco (UCSF), University of California, Santa Cruz (UCSC) Spinoff Circle Scores Seed Funding From QB3’s VC Fund, Pfizer (PFE) 9/22/2014 7:05:56 AM
Boston Therapeutics, Inc. Signs Clinical Trial Agreement With Prestigious Joslin Diabetes Center For Phase III Study Of BTI-320 9/22/2014 11:12:01 AM
Clinical Network Services Pty Ltd (CNS) And Ventac Partners Sign Cooperative Partnership 9/22/2014 10:40:28 AM